What are overvalued medical - diagnostics & research stocks?
They are Medical - Diagnostics & Research names trading above modeled intrinsic value—shown here as downside % versus price. Models vary; use this as a screen, not advice.
Search companies or stocks...
Top Overvalued Medical - Diagnostics & Research industry Stocks 2026
Thermo Fisher Scientific (TMO) is the most overvalued stock in the Medical - Diagnostics & Research industry with an estimated 19.7% downside, followed by IDEXX Laboratories, (IDXX) at 15.3%, Waters (WAT) at 11.7%, and Revvity, (RVTY) at 11.6%.
Updated todayBased on intrinsic value modelsIndustry: Medical - Diagnostics & Research
Page snapshot: 13 July 2026, 9:57 pm
Before you trade on valuation alone
Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.
Medical - Diagnostics & Research Industry Valuation Insights (Updated Today)
- The Medical - Diagnostics & Research industry currently shows an average upside of 14.6% on this snapshot.
- Top name Thermo Fisher Scientific Inc. (TMO) trades at roughly a 19.7% discount to modeled intrinsic value—rankings move with prices and inputs.
- This industry's average upside is below our broad overvalued benchmark (~21.7%).
Overvalued Medical - Diagnostics & Research Stocks by Market Cap
Large cap (top 5)
- 1.Thermo Fisher Scientific Inc. · TMO19.7%$195.86B
- 2.IDEXX Laboratories, Inc. · IDXX15.3%$44.46B
- 3.Waters Corporation · WAT11.7%$24.54B
- 4.Revvity, Inc. · RVTY11.6%$12.53B
Mid cap (top 5)
No qualifying names in this bucket on this snapshot.
Small cap (top 5)
No qualifying names in this bucket on this snapshot.
What Are Overvalued Medical - Diagnostics & Research Stocks?
Overvalued medical - diagnostics & research stocks are names where price sits above modeled fair (intrinsic) value—often expressed as positive headline downside versus the current quote.
This is not a sell list. Validate each symbol on its company page before you act.
How We Identify Overvalued Medical - Diagnostics & Research Stocks
We pull an industry-filtered overvalued snapshot (price, intrinsic value, downside, cap, sector, country) and rank by headline downside. You can sort and search in the table above.
Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.
FAQs
Answers about overvalued medical - diagnostics & research names, intrinsic value, and how often this list refreshes.
How do you find overvalued medical - diagnostics & research stocks?
We load overvalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.
Why are medical - diagnostics & research stocks overvalued?
Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.
Are overvalued medical - diagnostics & research stocks a good investment?
Not by label alone. Discounts can reflect risk or data lag. Check fundamentals and your goals; seek professional advice if needed.
How often is this list updated?
The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.